The Advance of the HSCT Evaluation at Single-Cell Scale --Review
Hematopoietic stem cell transplantation (HSCT) is one of the effective options for the treatment of irradiation-induced injury on hematopoiesis, malignant hematological diseases, and numerous benign severe hematopathy. However, the cellular composition of the graft for HSCT, as well as the significant events of transplanted HSCs in receipients including HSC homing, engraftment, differentiation, remains to be further elucidated. In recent years, with advances in single-cell techniques, the hematopoiesis has been decoding at single cell scale. In addition, single-cell RNA sequencing (scRNA-seq) has been used in the evaluation of hematopoietic dynamics post HSCT, which may be helpful to improve HSCT protocols and clinical outcomes. Hence, the recent advances of evaluating HSCT at single cell scale and the directions worthy paying attention to in the field have been reviewed briefly.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
---|---|
Enthalten in: |
Zhongguo shi yan xue ye xue za zhi - 31(2023), 5 vom: 17. Aug., Seite 1588-1593 |
Sprache: |
Chinesisch |
---|
Beteiligte Personen: |
Tang, Jie [VerfasserIn] |
---|
Links: |
---|
Themen: |
English Abstract |
---|
Anmerkungen: |
Date Revised 20.10.2023 published: Print Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.19746/j.cnki.issn.1009-2137.2023.05.054 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363393056 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM363393056 | ||
003 | DE-627 | ||
005 | 20231226093242.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||chi c | ||
024 | 7 | |a 10.19746/j.cnki.issn.1009-2137.2023.05.054 |2 doi | |
028 | 5 | 2 | |a pubmed24n1211.xml |
035 | |a (DE-627)NLM363393056 | ||
035 | |a (NLM)37846722 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a chi | ||
100 | 1 | |a Tang, Jie |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Advance of the HSCT Evaluation at Single-Cell Scale --Review |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 20.10.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Hematopoietic stem cell transplantation (HSCT) is one of the effective options for the treatment of irradiation-induced injury on hematopoiesis, malignant hematological diseases, and numerous benign severe hematopathy. However, the cellular composition of the graft for HSCT, as well as the significant events of transplanted HSCs in receipients including HSC homing, engraftment, differentiation, remains to be further elucidated. In recent years, with advances in single-cell techniques, the hematopoiesis has been decoding at single cell scale. In addition, single-cell RNA sequencing (scRNA-seq) has been used in the evaluation of hematopoietic dynamics post HSCT, which may be helpful to improve HSCT protocols and clinical outcomes. Hence, the recent advances of evaluating HSCT at single cell scale and the directions worthy paying attention to in the field have been reviewed briefly | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a hematopoietic stem cell transplantation | |
650 | 4 | |a radiation injury | |
650 | 4 | |a single cell sequencing | |
650 | 4 | |a single-cell scale | |
700 | 1 | |a Li, Xiao-Tong |e verfasserin |4 aut | |
700 | 1 | |a Li, Pei-Lin |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Heng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Zhongguo shi yan xue ye xue za zhi |d 2000 |g 31(2023), 5 vom: 17. Aug., Seite 1588-1593 |w (DE-627)NLM122963113 |x 1009-2137 |7 nnns |
773 | 1 | 8 | |g volume:31 |g year:2023 |g number:5 |g day:17 |g month:08 |g pages:1588-1593 |
856 | 4 | 0 | |u http://dx.doi.org/10.19746/j.cnki.issn.1009-2137.2023.05.054 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 31 |j 2023 |e 5 |b 17 |c 08 |h 1588-1593 |